drugset / Trial / NCT06205199

Analgesic Effect of Ropivacaine Combined With Hydromorphone for CSEA After Total Knee Arthroplasty

NCT06205199

Completed 136 enrolled Second Hospital of Jilin University
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to investigate the continuous analgesic effect and side effects of ropivacaine combined with hydromorphone for combined spinal-epidural anesthesia(CSEA) after total knee arthroplasty and to explore its clinical application value. To observe whether hydromorphone combined with ropivacaine can promote the rapid recovery of patients.

Timeline

Start
2022-10-27
Primary completion
2023-11-30
Completion
2023-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydromorphone Other / unclassified 50 ug Other

Indications

No indication recorded.